Winton Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,229
| Closed | -$269K | – | 1182 |
|
|
2023
Q1 | $269K | Sell |
7,229
-580
| -7% | -$21.6K | 0.02% | 848 |
|
|
2022
Q4 | $354K | Buy |
7,809
+911
| +13% | +$41.3K | 0.02% | 744 |
|
|
2022
Q3 | $482K | Sell |
6,898
-1,001
| -13% | -$69.9K | 0.03% | 651 |
|
|
2022
Q2 | $530K | Buy |
7,899
+1,422
| +22% | +$95.4K | 0.03% | 679 |
|
|
2022
Q1 | $533K | Buy |
6,477
+4,922
| +317% | +$405K | 0.03% | 663 |
|
|
2021
Q4 | $228K | Sell |
1,555
-3,159
| -67% | -$463K | 0.01% | 913 |
|
|
2021
Q3 | $834K | Sell |
4,714
-419
| -8% | -$74.1K | 0.05% | 593 |
|
|
2021
Q2 | $829K | Sell |
5,133
-970
| -16% | -$157K | 0.04% | 635 |
|
|
2021
Q1 | $1.05M | Sell |
6,103
-493
| -7% | -$84.4K | 0.06% | 434 |
|
|
2020
Q4 | $1.45M | Sell |
6,596
-14,216
| -68% | -$3.12M | 0.1% | 228 |
|
|
2020
Q3 | $3.46M | Buy |
+20,812
| New | +$3.46M | 0.11% | 266 |
|
|
2019
Q1 | – | Sell |
-7,300
| Closed | -$310K | – | 1213 |
|
|
2018
Q4 | $310K | Buy |
7,300
+1,787
| +32% | +$75.9K | 0.01% | 646 |
|
|
2018
Q3 | $260K | Buy |
+5,513
| New | +$260K | 0.01% | 878 |
|